Skip to main content

Table 3 Evolution of the respiratory and gazometric parameters during the study

From: Right over left ventricular end-diastolic area relevance to predict hemodynamic intolerance of high-frequency oscillatory ventilation in patients with severe ARDS

 

CMVpre

HFOV connection

H1 HFOV

H3 HFOV

Concerned patients number

24

24

23

19

mPaw (cm H2O)

19 ± 3b,c,d

29 ± 1a

28 ± 1a

29 ± 1a

Frequency (Hz)

NA

6.0 ± 0.0d

6.0 ± 0.0d

5.2 ± 1.3b,c

Amplitude (cm H2O)

NA

88 ± 13

86 ± 12

85 ± 12

Pressure amplitude of oscillation (%)

NA

80 ± 0

79 ± 4

79 ± 5

pH

7.24 ± 0.14d

NA

7.25 ± 0.16

7.30 ± 0.17a

PaCO2 (mmHg)

53 ± 15d

NA

49 ± 19a

47 ± 15a

Bicarbonate (mmol L−1)

24 ± 5

NA

23 ± 6

24 ± 4

Base excess (mmol L−1)

−6 ± 6d

NA

−6 ± 7d

−4 ± 5a,c

P/F ratio

89 ± 23c,d

NA

171 ± 106a

177 ± 96a

OI

26 ± 8d

NA

26 ± 17d

23 ± 15a,c

ELWI (mL/kg PBW)

19 ± 7

19 ± 7

19 ± 7

17 ± 6

PVPI

5.1 ± 1.7

5.2 ± 1.8

5.1 ± 1.5

5.1 ± 1.7

  1. Results are given as mean ± SD
  2. CMV conventional mechanical ventilation, HFOV high frequency oscillation ventilation, mPaw mean airway pressure, FiO 2 fraction of inspired oxygen, P/F ratio of arterial oxygen concentration to the fraction of inspired oxygen, OI oxygenation index calculated as (mean airway pressure × FiO2)/PaO2, ELWI extravascular lung water index, PBW predicted body weight, PVPI pulmonary vascular permeability index
  3. a p < 0.05 for all data as compared to CMVpre
  4. b p < 0.05 for all data as compared to HFOV connection
  5. c p < 0.05 for all data as compared to H1 HFOV
  6. d p < 0.05 for all data as compared to H3 HFOV